GIP[3-30]NH2

N/A

Report date: 2025/03/27 20:00:06

Base Information

Drug NameGIP[3-30]NH2
Drug Alias NameGIP[3-30]NH2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor antagonists
TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A